Quantitative polymerase chain reaction for hepatitis B virus DNA

Area of Science:

• Virology
• Molecular Biology
• Hepatology

Background:

• Accurate quantification of hepatitis B virus (HBV) DNA is crucial for monitoring antiviral drug efficacy in patients.
• Conventional polymerase chain reaction (PCR) lacks accuracy for HBV DNA quantification due to sample variability.
• High sensitivity and precision are required for reliable HBV DNA measurement.

Purpose of the Study:

• To develop a sensitive and accurate quantitative method for monitoring HBV DNA levels.
• To establish a competitive PCR assay with an internal standard for precise HBV DNA quantification.
• To evaluate the effect of 2'-deoxyguanosine (2'-CDG) on HBV replication using the developed method.

Main Methods:

• Developed a competitive PCR method utilizing an internal standard derived from the HBV S gene.
• The internal standard was engineered with a single base modification to introduce a restriction enzyme site.
• Applied the competitive PCR assay to quantify HBV DNA in 2.2.15 cells treated with 2'-CDG.

Main Results:

• The competitive PCR method demonstrated high sensitivity, detecting HBV DNA in the attomole range.
• A significant decrease in HBV DNA levels was observed in 2.2.15 cells treated with 2'-CDG.
• Results were validated using conventional HBV DNA slot blot analysis and densitometry.

Conclusions:

• Competitive PCR with an internal standard provides a sensitive, accurate, and reliable method for HBV DNA quantitation.
• The assay is effective for assessing the impact of antiviral agents like 2'-CDG on HBV replication.
• This method enhances the ability to monitor and compare drug effects in hepatitis patients.